Copenhagen the best choice for EMA


40 people representing companies, organisations, politicians and institutions in Denmark and Southern Sweden have signed a letter to President Juncker, President Tusk and President Tajani at the EU Commission to urge a decision on placement of EMA in Copenhagen.

Copenhagen the best choice for EMA

The letter begins: Over the coming months, the decision on where to relocate the European Medicines Agency (EMA) will be on the table for you as a European decision-maker. We are representatives of a broad coalition of public and private institutions in Denmark deeply involved in and dependent on a well-functioning European medicines authority. We believe Copenhagen offers optimal conditions for hosting the EMA thanks to the presence of a world-class research environment, an innovative and vibrant life science cluster, a unique basis for a strong focus on patient and animal safety, an efficient infrastructure, and high liveability for employees and their families. Allow us to elaborate.

Part of the arguments
Being the EU country with most clinical trials per capita, Denmark is a leader in terms of research focusing on medicines safety and efficacy. Denmark was among the first countries to introduce a compulsory reporting system on adverse events. Together with our long-standing health registries, this makes Denmark the epicentre for the use of real-world data in terms of patient safety. Welcoming EMA to Copenhagen would fur-ther strengthen our joint efforts in this field.

The Greater Copenhagen area is under continuous, rapid development. From outstanding, green urban architecture, as exemplified by the new UN City, to monumental infrastructure projects, progress is steady and visionary. Today, Denmark is the number one EU country in terms of digital infrastructure according to the European Commission.

Read the whole letter here.

Latest news

Overwhelming interest from leading speakers in First Nordic conference on personalized medicine 11-04-2018
The conference in Nyborg looks mainly at the underlying mechanisms causing variability in clinical response and drug toxicity. We talked to organizer...
Cancer therapies: How we link drug sensitivity to molecular profiling to identify biomarkers 23-03-2018
Professor Krister Wennerberg talks on stratified cancer therapies and their predictive biomarkers at the Oncology Network meeting April 9th.
Biopeople i nyt samarbejde med magasinet Life Science 22-03-2018
I 2018 har Biopeople indgået et samarbejde med bladet Life Science – Dansk Biotek (in Danish only).
Call: USA East Coast Innovation Tour - Greater Boston & Greater New York - deadline March 30th 21-03-2018
The Innovation Tour is specifically focused on life science companies from Europe to explore research, commercialization and investment opportunities...
Internationalt uddannelsessamarbejde inden for regulering af medicin 20-03-2018
Den 27. februar 2018 arrangerede Biopeople og Copenhagen Centre for Regulatory Science en international workshop for mere end 25 unge forskere fra...


What are you looking for?
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.